Answers are grounded in this paper and cite their sources.
Demonstrates enhanced CO2 conversion in catalysts via Mn doping and morphology optimization, indicating improved performance.
The rational design of catalysts for the selective conversion of CO2 and monoethanolamine (MEA) into 1-(2-hydroxyethyl)-2-imidazolidinone (HEIA) remains a significant challenge. Herein, we present a synergistic strategy combining morphology engineering and electronic modulation to develop high-performance CeO2-based catalysts. Initial morphology control revealed that spindle-like CeO2 (F-CeO2), with its high surface area, abundant oxygen vacancies, and tip-enhanced local effects (meaning higher reactivity at sharp or tip-like regions), exhibits superior performance over spherical, octahedral, and cubic morphologies. Subsequent electronic modulation via Mn doping further enhanced the catalytic performance compared with undoped F-CeO2: the oxygen vacancy concentration increased by 38.6%, the distribution of surface basic sites shifted to be dominated by 81.20% weak basic sites, and the HEIA yield achieved an approximately 10% improvement. Mechanistic studies confirm that the abundant weak basic sites are crucial for selectively promoting the intermolecular dehydration pathway to HEIA, while suppressing competing reactions. This work provides a clear and effective blueprint for designing advanced CeO2 catalysts for selective CO2 utilization.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: